RT Book, Section
A1 McCaffery, Kirsten Jo
A1 Jacklyn, Gemma Louise
A1 Barratt, Alexandra
A1 Brodersen, John
A1 Glasziou, Paul
A1 Carter, Stacy M.
A1 Hicks, Nicholas R.
A1 Howard, Kirsten
A1 Irwig, Les
A2 Guyatt, Gordon
A2 Rennie, Drummond
A2 Meade, Maureen O.
A2 Cook, Deborah J.
SR Print(0)
ID 1183878449
T1 Recommendations About Screening
T2 Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-179071-0
LK jamaevidence.mhmedical.com/content.aspx?aid=1183878449
RD 2023/03/26
AB CLINICAL  SCENARIOYou  are  a  primary  care  physician  advising  a  50-year-old  woman  who  is  concerned  because  a  friend  of  hers  was  recently  diagnosed  as  having  breast  cancer  and  has  urged  her  to  undergo  mammography  screening  because  “it's  better  to  be  safe  than  sorry.”The  woman  does  not  have  a  family  history  of  breast  or  ovarian  cancer  or  a  breast  lump.  She  asks  whether  you  agree  that  she  should  undergo  screening.  You  know  that  trials  of  mammography  screening  support  both  a  mortality  reduction  from  breast  cancer  and  the  existence  of  overdetection  and  false-positive  results,  which  may  result  in  unnecessary  investigations  and  overtreatment.  You  are  unsure  of  the  magnitude  of  these  effects,  which  you  know  are  crucial  in  helping  your  patient  to  make  her  decision.  To  help,  you  need  to  know  how  screening  can  be  evaluated,  how  screening  test  results  should  be  interpreted,  and  whether  there  are  any  valid,  relevant,  and  up-to-date  clinical  practice  guidelines  or  recommendations  about  screening  for  breast  cancer.